External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home HOPA 2024
Roche and Genentech at

HOPA 2024

April 03 - April 06
Tampa, Florida
hoparx.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:00 PM
Duration 2hrs Tampa, Florida
IMscin001 Part 2 updated results: Efficacy, safety, immunogenicity, healthcare provider perspectives and patient-reported outcomes from the randomised Phase III study of atezolizumab subcutaneous vs intravenous in patients with locally advanced or metastatic non-small-cell lung cancer
Mauricio Burotto, Zanete Zvirbule, Renzo Alvarez, Busayamas Chewaskulyong, Luis A. Herraez-Baranda, Esther Shearer-Kang, Xiaoyan Liu, Nadia Tosti, Patrick Williams, Amparo Yovanna Castro Sanchez, James Zanghi, Enriqueta Felip
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.